Kübra Öztürk
-
- IL-33, ST2, and ILC Pathways 6
- interferon and immune responses 4
-
- Renal Diseases and Glomerulopathies 3
-
- Inflammasome and immune disorders 17
-
- Autoimmune and Inflammatory Disorders Research 11
-
- Kawasaki Disease and Coronary Complications 9
-
- Coronary Artery Anomalies 3
-
- Ocular Diseases and Behçet’s Syndrome 3
- Co-authors
- Mustafa ÇakanRob van BinnendijkAnne‐Marie BuismanZelal EkinciNuray Aktay AyazBetül SözeriGülçin Otar YenerHafize Emine Sönmez
- Cited by
- ImmunologyMicrobiologyNephrology
- Journals
- Clinical Rheumatology (4 papers)European Journal of Pediatrics (4 papers)Modern Rheumatology (2 papers)
- Partner nations
- TürkiyeUnited StatesSomalia
In The Last Decade
Kübra Öztürk
37 papers receiving 344 citations
Peers
Comparison fields: 5 of 68
- Immunology 120
- Microbiology 31
- Nephrology 34
- Rheumatology 72
- Otorhinolaryngology 18
Countries citing papers authored by Kübra Öztürk
This map shows the geographic impact of Kübra Öztürk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kübra Öztürk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kübra Öztürk more than expected).
Fields of papers citing papers by Kübra Öztürk
This network shows the impact of papers produced by Kübra Öztürk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kübra Öztürk. The network helps show where Kübra Öztürk may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Kübra Öztürk, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 2 | |
| 5 | 2024 | 0 | |
| 6 | 2023 | 2 | |
| 7 | 2023 | 0 | |
| 8 | 2023 | 1 | |
| 9 | 2023 | 1 | |
| 10 | 2022 | 6 | |
| 11 | 2022 | 1 | |
| 12 | 2021 | 6 | |
| 13 | 2021 | 13 | |
| 14 | 2021 | 7 | |
| 15 | 2021 | 13 | |
| 16 | 2020 | 3 | |
| 17 | 2020 | 6 | |
| 18 | 2020 | 20 | |
| 19 | HEMŞİRELİK ÖĞRENCİLERİNİN TIBBİ HATALARA KARŞI TUTUMLARI | 2019 | 1 |
| 20 | 2012 | 23 |
About Kübra Öztürk
Kübra Öztürk is a scholar working on Hematology, Nephrology, Immunology, Medical Laboratory Technology and Rheumatology, having authored 46 papers that have together received 353 indexed citations. Recurring topics across this work include Inflammasome and immune disorders (17 papers), Autoimmune and Inflammatory Disorders Research (11 papers), Kawasaki Disease and Coronary Complications (9 papers), IL-33, ST2, and ILC Pathways (6 papers), interferon and immune responses (4 papers), Renal Diseases and Glomerulopathies (3 papers), Coronary Artery Anomalies (3 papers) and Ocular Diseases and Behçet’s Syndrome (3 papers). The work is most often cited by research in Immunology (120 citations), Microbiology (31 citations), Nephrology (34 citations), Rheumatology (72 citations) and Otorhinolaryngology (18 citations). Kübra Öztürk has collaborated with scholars based in Türkiye, United States and Somalia. Frequent co-authors include Mustafa Çakan, Rob van Binnendijk, Anne‐Marie Buisman, Zelal Ekinci, Nuray Aktay Ayaz, Betül Sözeri, Gülçin Otar Yener, Hafize Emine Sönmez, Şerife Gül Karadağ and Esra Bağlan. Their work appears in journals such as Clinical Rheumatology, European Journal of Pediatrics, Modern Rheumatology, Frontiers in Pediatrics and Lupus.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.